MapLight Therapeutics, Inc. Common Stock (MPLT) is a publicly traded the market company. As of September 18, 2026, MPLT trades at $10.88 with a market cap of $525.00M and a P/E ratio of -0.57. MPLT moved -3.98% today. Year to date, MPLT is -34.88%; over the trailing twelve months it is flat. Its 52-week range spans $9.10 to $40.43. Analyst consensus is strong buy with an average price target of $28.00. Rallies surfaces MPLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MPLT news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $10.88 |
| Market Cap | $525.00M |
| P/E Ratio | -0.57 |
| EPS | $-18.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.43 |
| 52-Week Low | $9.10 |
| Volume | 414.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-161.15M |
| Gross Margin | 0.00% |
10 analysts cover MPLT: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.00.